| Variables |
groups |
Mean of differences |
P- value |
| Raloxifene/ experimental
N=18 |
Placebo/control
N=19 |
| BMI (Kg/m2) |
30.6 ± 4.1 |
29.4 ± 4.3 |
1.21 |
0.423 |
| SBP(mmHg) |
135 ± 19.9 |
134.4 ± 17.9 |
1.5 |
0.81 |
| DBP(mmHg) |
81 ± 7.5 |
85.3 ± 10.2 |
-3.4 |
0.35 |
| HbA1C(mg/dL) |
7.9 ± 2.1 |
7.7 ± 1.7 |
-0.14 |
0.83 |
| TG(mg/dL) |
240.4 ± 98.6 |
165.1 ± 78.2 |
75.3 |
0.0231 |
| Chol(mg/dL) |
200.6 ± 47.2 |
186.4 ± 41.7 |
14.2 |
0.372 |
| HDL(mg/dL) |
40.9 ± 5.1 |
43.7 ± 6.4 |
2.8 |
0.18 |
| LDL(mg/dL) |
112.2 ± 44.1 |
108.8 ± 38.1 |
3.4 |
0.81 |
| ACR log |
1.89 ± 0.8 |
2.12 ± 0.83 |
-0.23 |
.043 |
| GFR(ml/min) |
66.3 ± 17.1 |
69 ± 22.9 |
2.7 |
0.70 |
1-P value< 0.05 is considered statistically significant
BMI: Body Mass Index; SBP: Systolic Blood Pressure; DBP: Diastolic Blood
Pressure; TG: Triglyceride; Chol: Cholesterol; HDL: High Density Lipoprotein; LDL:
Low Density Lipoprotein; ACR: Albumin to Creatinin ratio; ACR log: Logarithm of
ACR; GFR: Glomerular Filtration Rate |
